3,7,8,2'-Tetrahydroxyflavone
3,7-Dihydroxyflavone
4'-Dimethylamino-7,8-dihydroxyflavone
7,3′-Dihydroxyflavone
7,8,2'-Trihydroxyflavone
7,8,3'-Trihydroxyflavone
7,8-Dihydroxyflavone
8-Hydroxyquinoline
ABT-110
ALE-0540
AM7 (drug)
AMG-458
ANA-12
ARA-290
ASP-6294
ATC code L03
AVE-1642
AZD-1480
AZD-6918
Abrocitinib
Acute respiratory distress syndrome
Adrenomedullin
Afatinib
Affordable Care Act
Aflibercept
Agerafenib
Alacizumab pegol
Albinterferon
Allergic reactions
Altiratinib
American Society of Health-System Pharmacists
Amitriptyline
Amphiregulin
Amuvatinib
Anatomical Therapeutic Chemical Classification System
Ancestim
Angiopoietin 1
Angiopoietin 2
Angiopoietin 3
Angiopoietin 4
Angiopoietin receptor
Anifrolumab
Aprutumab
Aprutumab ixadotin
Artemin
Asialo erythropoietin
Atiprimod
Avapritinib
Axitinib
Axokine
BMS-754807
BMS-777607
BNN-20
BNN-27
Bacillus Calmette–Guérin
Baricitinib
Becaplermin
Beta-glucan
Betacellulin
Bevacizumab
Bifarcept
Biologics Price Competition and Innovation Act of 2009
Biosimilar
Biosimilars
Bleeding
Brain-derived neurotrophic factor
Brigatinib
Burosumab
CAS Registry Number
CD117
CE-245677
CH-7057288
CHZ868
CNTO-530
CSPG5
CYT387
Cabozantinib
Canertinib
Capmatinib
Carbamylated erythropoietin
Cardiotrophin 1
Cediranib
Cenegermin
Cercosporamide
Cerebrolysin
Cetuximab
ChEMBL
ChemSpider
Chemical formula
Chemokine receptor
Chemotherapy
Ciliary neurotrophic factor receptor
Cilmostim
Cixutumumab
Colony-stimulating factor
Colony-stimulating factor receptor
Committee for Medicinal Products for Human Use
Connective tissue growth factor
Crenolanib
Crizotinib
Cucurbitacin I
Cyclotraxin B
Cytokine
Cytokine receptor
DMAQ-B1
DS-6051
Dacomitinib
DailyMed
Dalotuzumab
Dapiclermin
Darbepoetin alfa
Dasatinib
Decernotinib
Dehydroepiandrosterone
Dehydroepiandrosterone sulfate
Deoxygedunin
Depatuxizumab
Depatuxizumab mafodotin
Deprenyl
Des(1-3)IGF-1
Deucravacitinib
Deuruxolitinib
Dexamethasone
Dihexa
Diosmetin
Doi (identifier)
DrugBank
Drug class
Drug nomenclature
Drugs.com
Duligotumab
Dusigitumab
ECHA InfoCard
EFNA1
EFNA2
EFNA3
EFNA4
EFNA5
EFNB1
EFNB2
EFNB3
EVT-901
Ecogramostim
Efbemalenograstim alfa
Eflapegrastim
Eltrombopag
Emapalumab
Emfilermin
Emibetuzumab
Entrectinib
Ephrin
Epidermal growth factor
Epidermal growth factor receptor
Epigen
Epiregulin
Epoetin alfa
Epoetin beta
Epoetin delta
Epoetin epsilon
Epoetin gamma
Epoetin kappa
Epoetin omega
Epoetin theta
Epoetin zeta
Erlotinib
Ersofermin
Ertumaxomab
Erythropoietin
Erythropoietin-Fc
Erythropoietin receptor
European Medicines Agency
Evinacumab
FGF1
FGF10
FGF15/19
FGF17
FGF18
FGF19
FGF2
FGF20
FGF22
FGF23
FGF3
FGF4
FGF5
FGF6
FGF7
FGF8
FGF9
FMS-like tyrosine kinase 3 ligand
FX007
Faralimomab
Fasinumab
Febrile neutropenia
Female sex steroids
Fibroblast growth factor
Fibroblast growth factor receptor
Fibroblast growth factor receptor 1
Fibroblast growth factor receptor 2
Fibroblast growth factor receptor 3
Fibroblast growth factor receptor 4
Ficlatuzumab
Figitumumab
Filgotinib
Filgrastim (data page)
Flanvotumab
Fontolizumab
Food and Drug Administration
Foretinib
Fosgonimeton
Frunevetmab
Fruquintinib
Fulranumab
Futuximab
GBR-900
GFRα1
GFRα2
GFRα3
GFRα4
GZ-389988
Gambogic amide
Ganitumab
Gefitinib
Glatiramer acetate
Glia maturation factor
Glial cell line-derived neurotrophic factor
Glucose-6-phosphate isomerase
Glypromate
Golvatinib
Gossypetin
Grandinin
Granulocyte-macrophage colony-stimulating factor
Granulocyte colony-stimulating factor
Granulocyte colony-stimulating factor receptor
Granulocyte macrophage colony-stimulating factor
Granulocyte macrophage colony-stimulating factor receptor
Growth factor receptor
Growth hormone
Guide to Pharmacology
HER2/neu
HER3
HER4
HIOC
HIV/AIDS
Hdl (identifier)
Health Canada
Hemoptysis
Heparin-binding EGF-like growth factor
Hepatocyte growth factor
Hepatocyte growth factor receptor
Hepatoma-derived growth factor
Heterocyclic compound
Histamine dihydrochloride
IFNA10
IFNA13
IFNA14
IFNA16
IFNA17
IFNA2
IFNA21
IFNA4
IFNA5
IFNA6
IFNA7
IFNA8
IFNB1
IFNB3
IGF-1 LR3
IGFBP1
IGFBP2
IGFBP3
IGFBP4
IGFBP5
IGFBP6
IGFBP7
INCB28060
ISBN (identifier)
IUPAC nomenclature of chemistry
Icotinib
Icrucumab
Imatinib
Imgatuzumab
Immunocyanin
Immunostimulant
Indicated
Infigratinib
Inosine pranobex
Insulin
Insulin-like growth factor-binding protein
Insulin-like growth factor 1
Insulin-like growth factor 1 receptor
Insulin-like growth factor 2
Insulin-like growth factor 2 receptor
Interferon
Interferon-alpha/beta receptor
Interferon-gamma receptor
Interferon-lambda receptor
Interferon alfa
Interferon alfa 2a
Interferon alfa 2b
Interferon alfa n1
Interferon alfacon-1
Interferon alpha
Interferon alpha-n3
Interferon alpha 1
Interferon beta
Interferon beta 1a
Interferon beta 1b
Interferon gamma
Interferon gamma 1b
Interferon kappa
Interferon omega
Interferon receptor
Interleukin
Interleukin-34
Interleukin 2
Interleukin receptor
Intraveneous
Intravenous
JAK1
JAK2
JAK3
JNJ-38877605
Janus kinase
Janus kinase inhibitor
K252a
KEGG
Keratinocyte growth factor
LEVI-04
LM22A-4
Lanimostim
Lapatinib
Larotrectinib
Lenograstim
Lentinan
Lenvatinib
Leridistim
Lestaurtinib
Leukapheresis
Leukemia inhibitory factor
Liatermin
Linsitinib
Lipegfilgrastim
Low-affinity nerve growth factor receptor
MEDI-545
MEDI-578
MK-2461
Macrophage-stimulating protein
Macrophage colony-stimulating factor
Macrophage colony-stimulating factor receptor
Masitinib
Matuzumab
Mavrilimumab
Mecasermin
Mecasermin rinfabate
Medication
MedlinePlus
Melanoma vaccine
Methoxy polyethylene glycol-epoetin beta
Midkine
Midostaurin
Mifamurtide
Migration-stimulating factor
Milciclib
Milodistim
Mirimostim
Molar mass
Molgramostim
Momelotinib
Motesanib
Mubritinib
Murodermin
N-Acetylserotonin
NRG2
NRG3
NRG4
NSC-33994
NSC-7908
NVP-ADW742
NVP-AEW541
Namilumab
Nartograstim
Necitumumab
Nepidermin
Neratinib
Nerve growth factor
Nesvacumab
Neuregulin
Neuregulin-1
Neurotrophin-3
Neurotrophin-4
Neurturin
Neutropenia
Neutrophil
Nilotinib
Nimotuzumab
Nintedanib
Norwogonin
OCLC (identifier)
ONO-4474
ONO-5390556
OSl-906
Oclacitinib
Olaratumab
Oligopeptide
Onartuzumab
Oncomodulin
Oncostatin M
Oprelvekin
Osimertinib
Otilimab
PDGFA
PDGFB
PDGFC
PDGFD
PF-04217903
PF-2341066
PHA-665752
PLX-7486
PMID (identifier)
Pacritinib
Palifermin
Panitumumab
Patritumab
Pazopanib
Peficitinib
Pegacaristim
Pegademase
Pegaptanib
Pegfilgrastim
Peginesatide
Peginterferon alfa-2a
Peginterferon alfa-2b
Pegnartograstim
Pegol sihematide
Persephin
Pertuzumab
Pidotimod
Pituitary adenylate cyclase-activating peptide
Placental growth factor
Platelet-derived growth factor
Platelet-derived growth factor receptor
Pleiotrophin
Plerixafor
Poly ICLC
Polyribonucleotide
Pregnancy
Pregnancy category
Prescription drug
Prolactin
Promegapoietin
Pulmonary alveolus
Quizartinib
R13 (drug)
R1507
R7 (drug)
RBM-004
RET proto-oncogene
Radiation poisoning
Radotinib
Ramucirumab
Ranevetmab
Ranibizumab
ReN-1820
Rebastinib
Receptor modulator
Recombinant feline interferon omega
Regorafenib
Regramostim
Regulation of therapeutic goods
Renalase
Repifermin
Rilotumumab
Ripretinib
Ritlecitinib
Robatumumab
Romiplostim
Rontalizumab
Ropeginterferon alfa-2b
Roquinimex
Route of administration
Ruptured spleen
Ruxolitinib
S2CID (identifier)
SD-1008
SNA-120
SU-11274
Sargramostim
Selpercatinib
Semaxanib
Seribantumab
Sickle cell crisis
Sifalimumab
Sipuleucel-T
Somatomedin receptor
Sorafenib
Splenic rupture
Sprifermin
Stem cell factor